xalkori pricing

Crizonix (crizotinib) is a kinase inhibitor indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK) or ROS1-positive as detected by an FDA-approved test.

Crizonix’s brand name is XALKORI® by Pfizer. Crizonix is a generic oncologic prescription medicine from Beacon, which is one of the biggest pharmaceutical company in Bangladesh. Visit https://www.bonhoa.com/featured-product/46-crizotinib-xalkori-capsules-250mg.html